Candriam Equities L Biotechnology Class I USD CapRegister to Unlock Ratings |
Growth Of 1000 (GBP) | 31/10/2024 |
|
Annual Returns (GBP) | 31/10/2024 | |||||||
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 31/10 | |
Price Return | 15.50 | -4.57 | 28.56 | 17.57 | -0.73 | 9.79 | 1.49 | 9.18 |
+/- Category | 5.21 | 3.39 | 8.36 | -8.40 | 8.30 | 17.62 | 2.77 | 7.73 |
+/- Category Index | 0.31 | -2.73 | 11.85 | -15.37 | -1.03 | 7.32 | -5.84 | 3.37 |
% Rank in Category | 24 | 32 | 14 | 61 | 34 | 3 | 30 | 13 |
Trailing Returns (GBP) | 21/11/2024 | ||
Total Returns | +/- Category | +/- Category Index | |
1 Day | 0.46 | -0.24 | 0.68 |
1 Week | -3.43 | 1.27 | -0.12 |
1 Month | -4.26 | 0.52 | 3.47 |
3 Months | -5.02 | -2.10 | 8.59 |
6 Months | 4.75 | 3.90 | 13.68 |
YTD | 6.59 | 7.15 | 5.78 |
1 Year | 22.46 | 7.43 | 15.77 |
3 Years Annualised | 5.58 | 10.20 | 3.68 |
5 Years Annualised | 7.66 | 2.89 | -0.89 |
10 Years Annualised | 8.57 | 1.44 | 0.30 |
Category: Sector Equity Biotechnology | |||
Category Index: Morningstar Gbl Biotechnology NR USD |
Quarterly Returns (GBP) | 31/10/2024 | |||
Quarter 1 | Quarter 2 | Quarter 3 | Quarter 4 | |
2024 | 3.72 | 2.98 | -0.40 | - |
2023 | -5.08 | -0.50 | -0.61 | 8.11 |
2022 | -4.88 | -0.16 | 12.93 | 2.38 |
2021 | -5.73 | 6.89 | 0.69 | -2.16 |
2020 | -4.77 | 25.59 | -5.57 | 4.11 |
2019 | 13.88 | 1.56 | -5.58 | 17.73 |
|
Advertisement |